Literature DB >> 32087840

A review of performance indicators of single-item alcohol screening questions in clinical and population settings.

Jueun Kim1, Christian S Hendershot2.   

Abstract

Screening and brief intervention (SBI) for unhealthy alcohol use is recommended as a routine clinical procedure for adults in primary care settings. However, implementation of SBI remains suboptimal, in part reflecting time constraints in clinical settings. Single Item Screening Questions (SISQ) have increasingly been studied as a means of minimizing assessment burden. Although the ability of SISQ to accurately detect unhealthy alcohol use (i.e., at-risk drinking or alcohol use disorder) has been studied in various clinical and population settings, results have not been summarized in aggregate. This descriptive summarizes SISQ performance metrics across various clinical settings and populations. Based on results from 40 identified studies, there is consistent support that SISQ have good sensitivity as screeners for unhealthy drinking, with performance generally being comparable to longer validated instruments. Collectively, these results justify further efforts to evaluate SISQ as a means of maximizing SBI uptake and efficiency in various clinical settings.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUDIT-3; At-risk drinking; NIAAA HED; Screening; Single-item

Mesh:

Year:  2020        PMID: 32087840     DOI: 10.1016/j.jsat.2020.01.006

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  2 in total

1.  Prevalence and Characteristics of Hospitalizations with Unhealthy Alcohol Use in a Safety-Net Hospital from 2016 to 2018.

Authors:  Marlene Martin; Joseph Clement; Triveni Defries; Anil N Makam; Oanh Kieu Nguyen
Journal:  J Gen Intern Med       Date:  2022-01-20       Impact factor: 6.473

Review 2.  Acute Pancreatitis: Diagnosis and Treatment.

Authors:  Peter Szatmary; Tassos Grammatikopoulos; Wenhao Cai; Wei Huang; Rajarshi Mukherjee; Chris Halloran; Georg Beyer; Robert Sutton
Journal:  Drugs       Date:  2022-09-08       Impact factor: 11.431

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.